Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
The Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. Vanguard Health Care ETF (VHT) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. XLVI is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.09% for VHT. XLVI is up 0.43% year-to-date (YTD) with +$2M in YTD flows. VHT performs worse with -1.5% YTD performance, and -$151M in YTD flows. Run a side-by-side ETF comparison of XLVI and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLVI VHT | -0.34%-1.42% | +2.91%+0.11% | +0.43%-1.50% | n/a+7.50% | n/a+30.03% | n/a+36.00% |
| Flows | XLVI VHT | +$788K-$76M | +$3M-$238M | +$2M-$151M | --$712M | --$2.54B | --$233M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLVI VHT | +10.28%+13.17% | n/a+17.33% | n/a+13.63% | n/a+14.97% |
| Max drawdown | XLVI VHT | -3.26%-5.00% | n/a-11.85% | n/a-16.88% | n/a-17.77% |
| Max drawdown duration | XLVI VHT | 9d62d | n/a190d | n/a435d | n/a767d |
XLVI | VHT | |
Last sale 3/11/2026 at 1:30 PM | $25.92 | $282.75 |
| Previous close 03/10/2026 | $25.98 | $283.48 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XLVI | VHT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XLVI | VHT | |
|---|---|---|
| Last price | $25.92 | $282.75 |
| 1D performance | -0.23% | -0.26% |
| AuM | $13.26 M | $16.92 B |
| E/R | 0.35% | 0.09% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
